98%
921
2 minutes
20
The worldwide production of bisphenol A (BPA) has doubled over the last two decades, reaching around 6.2 million tons in 2020, with a continuing rise. In contrast, arsenic (As) persists as a prevalent geogenic and anthropogenic contaminant in both global drinking water and surface water. Both substances are recognized as metabolic disruptors, targeting the liver with overlapping effects. Nonetheless, the combined hepatotoxic impacts of these substances and the molecular mechanisms involved remain inadequately understood. In this study, zebrafish, a widely acknowledged vertebrate model sharing significant genetic similarities with humans, was utilized to explore the separate and combined hepatotoxic effects of BPA and As, as well as the associated molecular mechanisms. Following a 28-day exposure, BPA and/or As induced marked hepatic damage, characterized by histopathological alterations, impaired liver function, oxidative stress, and dysregulated lipid metabolism. Notably, co-exposure to BPA and As amplified oxidative stress and lipid metabolic dysfunction, indicating enhanced toxicity under the combined treatment. Additionally, BPA and/or As exposure perturbed the hypothalamic‒pituitary‒thyroid (HPT) axis, as demonstrated by significantly decreased levels of thyrotropin-releasing hormone (TRH), thyroid‒stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4), accompanied by dysregulated expression of HPT axis-related genes (e.g., trα and trβ). Transcriptomic profiling of the liver implicated disruption of the peroxisome proliferator-activated receptor (PPAR) signaling pathway as a key contributor to oxidative stress and lipid metabolism dysregulation. Collectively, these findings reveal that BPA and As promote hepatotoxicity in zebrafish, likely through concurrent disruption of the HPT axis and the PPAR signaling pathway. This study provides novel mechanistic insights into the combined hepatotoxic effects of BPA and As, underscoring the importance of evaluating co-exposure risks in environmental and toxicological assessments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2025.127037 | DOI Listing |
Brief Bioinform
August 2025
College of Pharmacy, Chongqing Medical University, No. 1 Yixueyuan Road, Yuzhong District, Chongqing 400016, P. R. China.
Drug-induced hepatotoxicity (DIH), characterized by diverse phenotypes and complex mechanisms, remains a critical challenge in drug discovery. To systematically decode this diversity and complexity, we propose a multi-dimensional computational framework integrating molecular structure analysis with disease pathogenesis exploration, focusing on drug-induced intrahepatic cholestasis (DIIC) as a representative DIH subtype. First, a graph-based modularity maximization algorithm identified DIIC risk genes, forming a DIIC module and eight disease pathogenesis clusters.
View Article and Find Full Text PDFCureus
August 2025
Division of Infectious Diseases, Hyogo Prefectural Kobe Children's Hospital, Hyogo, JPN.
Tuberculous meningitis (TBM) is predominantly observed in developing countries but remains relatively rare in developed countries. Therefore, if a clinician does not suspect TBM, its diagnosis may be delayed. Furthermore, drug-induced hepatotoxicity is common and can become severe during TBM treatment.
View Article and Find Full Text PDFCureus
August 2025
Internal Medicine, Hospital Corporation of America (HCA) Florida Westside Hospital, Plantation, USA.
This is a case of drug-induced liver injury (DILI) in a 75-year-old male patient with a history of metastatic melanoma, who initially presented with a syncopal episode causing a fall. Following stabilization in the emergency department (ED), the patient was found to have bilateral subdural hematomas, and later an MRI showed evidence of metastatic lesions in the brain with hemorrhagic conversion. These findings led to a prolonged inpatient stay in the intensive care unit and eventual development of pneumonitis, which was subsequently treated with hepatotoxic antibiotics despite initial labs showing mildly elevated liver enzymes.
View Article and Find Full Text PDFFront Pharmacol
August 2025
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.
Objective: To provide a comprehensive narrative synthesis of recent advances in the pharmacological actions and therapeutic potential of natural flavonoids in atopic dermatitis (AD), with emphasis on their multi-target pharmacological effects across core pathological mechanisms. The review also addresses pharmacokinetic limitations, formulation challenges, delivery innovations, safety concerns, and emerging clinical evidence to inform translational research and therapeutic development.
Methods: This narrative review is based on a targeted literature search of PubMed, Web of Science, ScienceDirect, and SpringerLink, covering English-language, peer-reviewed articles published between 2010 and 2025.
Recent Pat Anticancer Drug Discov
September 2025
Department of Biophysics, Faculty of Applied Health Sciences, October 6 University, Egypt.
Introduction: Leukemia and radiation-induced liver toxicity are significant health challenges requiring effective therapeutic strategies. This study aimed to evaluate the therapeutic efficacy and radiosensitizing effects of Diosgenin-loaded silver nanoparticles (Dio-AgNPs) in ENU-induced leukemic mice, with a focus on their dual role in mitigating leukemia progression and γ-irradiation-induced hepatotoxicity.
Methods: Dio-AgNPs were synthesized and characterized using TEM, UV-Vis spectroscopy, FT-IR spectroscopy, and encapsulation efficiency analysis.